Cargando…

DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia

SIMPLE SUMMARY: DUX4-rearrangement (DUX4r) is a recently discovered recurrent genomic lesion reported in 4–7% of childhood B cell acute lymphoblastic leukaemia (B-ALL) cases. This subtype has favourable outcomes, especially in children and adolescents treated with intensive chemotherapy. The fusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Rehn, Jacqueline A., O’Connor, Matthew J., White, Deborah L., Yeung, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599557/
https://www.ncbi.nlm.nih.gov/pubmed/33007870
http://dx.doi.org/10.3390/cancers12102815
_version_ 1783602904413765632
author Rehn, Jacqueline A.
O’Connor, Matthew J.
White, Deborah L.
Yeung, David T.
author_facet Rehn, Jacqueline A.
O’Connor, Matthew J.
White, Deborah L.
Yeung, David T.
author_sort Rehn, Jacqueline A.
collection PubMed
description SIMPLE SUMMARY: DUX4-rearrangement (DUX4r) is a recently discovered recurrent genomic lesion reported in 4–7% of childhood B cell acute lymphoblastic leukaemia (B-ALL) cases. This subtype has favourable outcomes, especially in children and adolescents treated with intensive chemotherapy. The fusion most commonly links the hypervariable IGH gene to DUX4 a gene located within the D4Z4 macrosatellite repeat on chromosome 4. DUX4r is cryptic to most standard diagnostic techniques, and difficult to identify even with next generation sequencing assays. This review summarises the clinical features and molecular genetics of DUX4r B-ALL and proposes prospective new diagnostic methods. ABSTRACT: DUX4-rearrangement (DUX4r) is a recently discovered recurrent genomic lesion reported in 4–7% of childhood B cell acute lymphoblastic leukaemia (B-ALL) cases. This subtype has favourable outcomes, especially in children and adolescents treated with intensive chemotherapy. The fusion most commonly links the hypervariable IGH gene to DUX4 a gene located within the D4Z4 macrosatellite repeat on chromosome 4, with a homologous polymorphic repeat on chromosome 10. DUX4r is cryptic to most standard diagnostic techniques, and difficult to identify even with next generation sequencing assays. This review summarises the clinical features and molecular genetics of DUX4r B-ALL and proposes prospective new diagnostic methods.
format Online
Article
Text
id pubmed-7599557
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75995572020-11-01 DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia Rehn, Jacqueline A. O’Connor, Matthew J. White, Deborah L. Yeung, David T. Cancers (Basel) Review SIMPLE SUMMARY: DUX4-rearrangement (DUX4r) is a recently discovered recurrent genomic lesion reported in 4–7% of childhood B cell acute lymphoblastic leukaemia (B-ALL) cases. This subtype has favourable outcomes, especially in children and adolescents treated with intensive chemotherapy. The fusion most commonly links the hypervariable IGH gene to DUX4 a gene located within the D4Z4 macrosatellite repeat on chromosome 4. DUX4r is cryptic to most standard diagnostic techniques, and difficult to identify even with next generation sequencing assays. This review summarises the clinical features and molecular genetics of DUX4r B-ALL and proposes prospective new diagnostic methods. ABSTRACT: DUX4-rearrangement (DUX4r) is a recently discovered recurrent genomic lesion reported in 4–7% of childhood B cell acute lymphoblastic leukaemia (B-ALL) cases. This subtype has favourable outcomes, especially in children and adolescents treated with intensive chemotherapy. The fusion most commonly links the hypervariable IGH gene to DUX4 a gene located within the D4Z4 macrosatellite repeat on chromosome 4, with a homologous polymorphic repeat on chromosome 10. DUX4r is cryptic to most standard diagnostic techniques, and difficult to identify even with next generation sequencing assays. This review summarises the clinical features and molecular genetics of DUX4r B-ALL and proposes prospective new diagnostic methods. MDPI 2020-09-30 /pmc/articles/PMC7599557/ /pubmed/33007870 http://dx.doi.org/10.3390/cancers12102815 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Rehn, Jacqueline A.
O’Connor, Matthew J.
White, Deborah L.
Yeung, David T.
DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia
title DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia
title_full DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia
title_fullStr DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia
title_full_unstemmed DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia
title_short DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia
title_sort dux hunting—clinical features and diagnostic challenges associated with dux4-rearranged leukaemia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599557/
https://www.ncbi.nlm.nih.gov/pubmed/33007870
http://dx.doi.org/10.3390/cancers12102815
work_keys_str_mv AT rehnjacquelinea duxhuntingclinicalfeaturesanddiagnosticchallengesassociatedwithdux4rearrangedleukaemia
AT oconnormatthewj duxhuntingclinicalfeaturesanddiagnosticchallengesassociatedwithdux4rearrangedleukaemia
AT whitedeborahl duxhuntingclinicalfeaturesanddiagnosticchallengesassociatedwithdux4rearrangedleukaemia
AT yeungdavidt duxhuntingclinicalfeaturesanddiagnosticchallengesassociatedwithdux4rearrangedleukaemia